nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Cell Assay for Detecting Anti-PEG Immune Response against PEG-Modified Therapeutics
|
Shimizu, Taro |
|
2018 |
35 |
11 |
p. 1-10 |
artikel |
2 |
Can Population Modelling Principles be Used to Identify Key PBPK Parameters for Paediatric Clearance Predictions? An Innovative Application of Optimal Design Theory
|
Calvier, Elisa A. M. |
|
2018 |
35 |
11 |
p. 1-12 |
artikel |
3 |
Cationic Liposomes: A Flexible Vaccine Delivery System for Physicochemically Diverse Antigenic Peptides
|
Heuts, Jeroen |
|
2018 |
35 |
11 |
p. 1-9 |
artikel |
4 |
CFD Supported Investigation of Shear Induced by Bottom-Mounted Magnetic Stirrer in Monoclonal Antibody Formulation
|
Ladner, Tobias |
|
2018 |
35 |
11 |
p. 1-11 |
artikel |
5 |
Co-Delivery of Teriflunomide and Methotrexate from Hydroxyapatite Nanoparticles for the Treatment of Rheumatoid Arthritis: In Vitro Characterization, Pharmacodynamic and Biochemical Investigations
|
Pandey, Shweta |
|
2018 |
35 |
11 |
p. 1-17 |
artikel |
6 |
Combination Metabolomics Approach for Identifying Endogenous Substrates of Carnitine/Organic Cation Transporter OCTN1
|
Masuo, Yusuke |
|
2018 |
35 |
11 |
p. 1-13 |
artikel |
7 |
Correction to: Bioreducible Poly(Amino Ethers) Based mTOR siRNA Delivery for Lung Cancer
|
Gandhi, Nishant S. |
|
2018 |
35 |
11 |
p. 1 |
artikel |
8 |
Correction to: Preclinical Development of Cell-Based Products: a European Regulatory Science Perspective
|
McBlane, James W. |
|
2018 |
35 |
11 |
p. 1 |
artikel |
9 |
Drug-Polymer Interaction, Pharmacokinetics and Antitumor Effect of PEG-PLA/Taxane Derivative TM-2 Micelles for Intravenous Drug Delivery
|
Wang, Qiao |
|
2018 |
35 |
11 |
p. 1-13 |
artikel |
10 |
Editorial, IAPC-6 Meeting
|
Tam, Kin |
|
2018 |
35 |
11 |
p. 1-2 |
artikel |
11 |
Enhancing Molecular Promiscuity Evaluation Through Assay Profiles
|
Avram, Sorin |
|
2018 |
35 |
11 |
p. 1-10 |
artikel |
12 |
Fabrication of TPGS-Stabilized Liposome-PLGA Hybrid Nanoparticle Via a New Modified Nanoprecipitation Approach: In Vitro and In Vivo Evaluation
|
Zhang, Mengyuan |
|
2018 |
35 |
11 |
p. 1-13 |
artikel |
13 |
Fragmentation of a Monoclonal Antibody by Peroxotungstate
|
Rathnayaka, Hasitha |
|
2018 |
35 |
11 |
p. 1-15 |
artikel |
14 |
Genetic Basis of Delayed Hypersensitivity Reactions to Drugs in Jewish and Arab Populations
|
Aboukaoud, Mohammed |
|
2018 |
35 |
11 |
p. 1-15 |
artikel |
15 |
Identification of D-Amino Acids in Light Exposed mAb Formulations
|
Bommana, Rupesh |
|
2018 |
35 |
11 |
p. 1-18 |
artikel |
16 |
Intra-Vial Heterogeneity in Physical Form of Mannitol in Colyophilized Binary Systems
|
Thakral, S. |
|
2018 |
35 |
11 |
p. 1-13 |
artikel |
17 |
Mitigation of Oxidation in Therapeutic Antibody Formulations: a Biochemical Efficacy and Safety Evaluation of N-Acetyl-Tryptophan and L-Methionine
|
Dion, Michelle Z. |
|
2018 |
35 |
11 |
p. 1-11 |
artikel |
18 |
Modeling Sex Differences in Anti-inflammatory Effects of Dexamethasone in Arthritic Rats
|
Song, Dawei |
|
2018 |
35 |
11 |
p. 1-9 |
artikel |
19 |
Molecular Targets of the Hydrophobic Block of Pluronics in Cells: a Photo Affinity Labelling Approach
|
Zhirnov, A. |
|
2018 |
35 |
11 |
p. 1-12 |
artikel |
20 |
Nanotechnology in Tuberculosis: State of the Art and the Challenges Ahead
|
Grotz, Estefania |
|
2018 |
35 |
11 |
p. 1-22 |
artikel |
21 |
Nasal Administration of Cationic Nanoemulsions as Nucleic Acids Delivery Systems Aiming at Mucopolysaccharidosis Type I Gene Therapy
|
Schuh, Roselena Silvestri |
|
2018 |
35 |
11 |
p. 1-11 |
artikel |
22 |
pH-Promoted Release of a Novel Anti-Tumour Peptide by “Stealth” Liposomes: Effect of Nanocarriers on the Drug Activity in Cis-Platinum Resistant Cancer Cells
|
Sacchetti, Francesca |
|
2018 |
35 |
11 |
p. 1-13 |
artikel |
23 |
Population Pharmacokinetic Modelling for Estimation of Remifentanil Metabolic-Ratio Using Non-steady-State Concentrations under Rapidly Adaptive Dosing
|
Simeoni, Monica |
|
2018 |
35 |
11 |
p. 1-11 |
artikel |
24 |
Population Pharmacokinetics and Exposure-Response Relationships of Naldemedine
|
Kubota, Ryuji |
|
2018 |
35 |
11 |
p. 1-11 |
artikel |
25 |
Probing Conformational Diversity of Fc Domains in Aggregation-Prone Monoclonal Antibodies
|
Majumder, Subhabrata |
|
2018 |
35 |
11 |
p. 1-12 |
artikel |
26 |
Progress in Inherited Retinal Disease Drug Discovery and Development: A Foundation’s Perspective
|
Yerxa, Benjamin |
|
2018 |
35 |
11 |
p. 1-4 |
artikel |
27 |
Quality Comparison of Biosimilar and Copy Filgrastim Products with the Innovator Product
|
Halim, Liem Andhyk |
|
2018 |
35 |
11 |
p. 1-12 |
artikel |
28 |
Radiolabeled PLGA Nanoparticles for Effective Targeting of Bendamustine in Tumor Bearing Mice
|
Khan, Iliyas |
|
2018 |
35 |
11 |
p. 1-11 |
artikel |
29 |
Selective Inhibition on Organic Cation Transporters by Carvedilol Protects Mice from Cisplatin-Induced Nephrotoxicity
|
Guo, Dong |
|
2018 |
35 |
11 |
p. 1-10 |
artikel |
30 |
Synthetically Lethal BMN 673 (Talazoparib) Loaded Solid Lipid Nanoparticles for BRCA1 Mutant Triple Negative Breast Cancer
|
Guney Eskiler, Gamze |
|
2018 |
35 |
11 |
p. 1-20 |
artikel |
31 |
Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations
|
Shen, Jie |
|
2018 |
35 |
11 |
p. 1-20 |
artikel |
32 |
Using Human Plasma as an Assay Medium in Caco-2 Studies Improves Mass Balance for Lipophilic Compounds
|
Katneni, Kasiram |
|
2018 |
35 |
11 |
p. 1-13 |
artikel |